RO23-6240 (AM-833), A NEW FLUOROQUINOLONE - INVITRO ANTIMICROBIAL ACTIVITY AND TENTATIVE DISK DIFFUSION INTERPRETIVE CRITERIA

被引：32

作者：

FUCHS, PC

JONES, RN

BARRY, AL

AYERS, LW

GAVAN, TL

GERLACH, EH

THORNSBERRY, C

机构：

[1] CLIN MICROBIOL INST,TUALATIN,OR

[2] ST FRANCIS HOSP,WICHITA,KS

[3] OHIO STATE UNIV,MED CTR,COLUMBUS,OH 43210

[4] CLEVELAND CLIN EDUC FDN,CLEVELAND,OH 44106

[5] CTR DIS CONTROL,ATLANTA,GA 30333

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1987年 / 7卷 / 01期

关键词：

D O I：

10.1016/0732-8893(87)90066-6

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：29 / 35

页数：7

共 7 条

[1] INVITRO ANTI-MICROBIAL ACTIVITY OF CEFOPERAZONE, CEFOTAXIME, MOXALACTAM (LY127935), AZLOCILLIN, MEZLOCILLIN, AND OTHER BETA-LACTAM ANTIBIOTICS AGAINST NEISSERIA-GONORRHOEAE AND HEMOPHILUS-INFLUENZAE, INCLUDING BETA-LACTAMASE-PRODUCING STRAINS [J].

BAKER, CN ;

THORNSBERRY, C ;

JONES, RN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (04) :757-761

[2] INVITRO ACTIVITY OF RO-23-6240, A NEW FLUORINATED 4-QUINOLONE [J].

CHIN, NX ;

BRITTAIN, DC ;

NEU, HC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :675-680

[3] EVALUATION OF INVITRO ANTIBACTERIAL ACTIVITY OF ENOXACIN - COMPARISON WITH OTHER ORALLY ABSORBED ANTIMICROBIAL AGENTS, PROPOSED DISK DIFFUSION TEST INTERPRETIVE CRITERIA, AND QUALITY-CONTROL LIMITS [J].

FUCHS, PC ;

BARRY, AL ;

JONES, RN ;

THORNSBERRY, C .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1985, 3 (03) :213-221

[4] PROPOSED DISK DIFFUSION SUSCEPTIBILITY CRITERIA FOR OFLOXACIN [J].

FUCHS, PC ;

BARRY, AL ;

JONES, RN ;

THORNSBERRY, C .

JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (02) :310-311

[5] INVITRO AND INVIVO ANTIBACTERIAL ACTIVITY OF AM-833, A NEW QUINOLONE DERIVATIVE [J].

HIRAI, K ;

AOYAMA, H ;

HOSAKA, M ;

OOMORI, Y ;

NIWATA, Y ;

SUZUE, S ;

IRIKURA, T .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) :1059-1066

[6]

1984, M2A3 NAT COMM CLIN L

[7]

1985, M7A NAT COMM CLIN LA

← 1 →